NextFin News - Shares of Czechoslovak Group (CSG) plummeted by a record 18% on Euronext Amsterdam on Monday, wiping out billions in market value after a scathing report from short-seller Hunterbrook Capital questioned the defense giant’s explosive growth and production capacity. The sell-off marks the sharpest single-day decline for the Prague-based conglomerate since its high-profile listing, as investors scrambled to digest allegations that the firm’s reported revenue from ammunition sales may be fundamentally disconnected from industrial reality.
Hunterbrook Capital, an investment firm that integrates investigative journalism with hedge fund trading, disclosed a short position in CSG alongside a report titled "Why the Largest Military IPO in European History Is Combusting." The firm, led by former journalists and intelligence analysts, has gained notoriety for its "headline hedge" strategy, which delivered a 23% return in the first nine months of 2025 by betting against companies it investigates. Hunterbrook’s core thesis centers on a perceived impossibility: CSG reported 6.74 billion euros in revenue for 2025—a tenfold increase in four years—yet its ammunition segment alone purportedly outearned the combined weapons and ammo divisions of Germany’s Rheinmetall, Europe’s established defense leader.
The report alleges that CSG’s claims of supplying nearly 4.1 billion euros in medium- and large-caliber ammunition in 2025 are "extraordinary" given the known constraints of European supply chains. According to Hunterbrook, the company’s reliance on Ukraine for 27% of its revenue and NATO countries for 65% masks undisclosed risks regarding the sustainability of these contracts and the actual origin of the hardware being sold. The short-seller further suggested that an internal investigation into a government official, which CSG previously described as a "procedural measure," may have deeper ties to the company’s procurement practices than management has admitted.
CSG has historically maintained an aggressive expansionist stance, positioning itself as the primary beneficiary of the European rearmament cycle following the invasion of Ukraine. The company’s management has frequently highlighted its "global strength," recently announcing a $2.5 billion air defense contract in Asia and a 250 million euro artillery deal with an unnamed European customer. However, Hunterbrook’s skepticism focuses on the "delta" between these announcements and the physical capacity to deliver, suggesting that the market has priced in a level of industrial throughput that CSG cannot realistically maintain without significant, and as yet unproven, capital expenditure.
The market reaction was swift and severe, but the report’s conclusions do not yet represent a consensus among sell-side analysts. Prior to Monday’s plunge, the average 12-month price target for CSG stood at 35.58 euros, with many analysts viewing the firm as a "top pick" for exposure to European strategic autonomy. These bullish valuations are predicated on the assumption that the "ammunition famine" in Ukraine provides a multi-year floor for CSG’s earnings. Critics of the short-seller report argue that Hunterbrook’s model may underestimate the efficiency of CSG’s private-equity-style lean operations compared to the more bureaucratic structures of legacy defense primes like Rheinmetall or BAE Systems.
From a technical standpoint, the 18% drop pushed CSG shares toward the 18.22 euro level, testing support zones that have held since the company’s initial surge in early 2025. The volatility underscores a broader anxiety within the defense sector: the fear that the "war-time" premiums applied to these stocks are vulnerable to any scrutiny regarding the transparency of their order books. While CSG has dismissed previous criticisms as misunderstandings of its unique supply chain model, the scale of Monday’s retreat suggests that institutional investors are no longer willing to take management’s production claims at face value without further verification.
The immediate fallout will likely center on CSG’s upcoming investor presentation, where management will be under intense pressure to provide granular data on factory utilization and raw material sourcing. If the company fails to provide a line-by-line rebuttal to Hunterbrook’s allegations regarding its ammunition revenue, the stock could face a prolonged period of de-rating. For now, the defense darling of Central Europe finds itself in a defensive crouch, battling a narrative that its meteoric rise was fueled more by aggressive accounting and geopolitical tailwinds than by industrial substance.
Explore more exclusive insights at nextfin.ai.
